1. Home
  2. DRTS vs GLO Comparison

DRTS vs GLO Comparison

Compare DRTS & GLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRTS
  • GLO
  • Stock Information
  • Founded
  • DRTS 2015
  • GLO 2006
  • Country
  • DRTS Israel
  • GLO United States
  • Employees
  • DRTS N/A
  • GLO N/A
  • Industry
  • DRTS Medical/Dental Instruments
  • GLO Finance/Investors Services
  • Sector
  • DRTS Health Care
  • GLO Finance
  • Exchange
  • DRTS Nasdaq
  • GLO Nasdaq
  • Market Cap
  • DRTS 256.2M
  • GLO 234.4M
  • IPO Year
  • DRTS N/A
  • GLO N/A
  • Fundamental
  • Price
  • DRTS $3.28
  • GLO $5.56
  • Analyst Decision
  • DRTS Strong Buy
  • GLO
  • Analyst Count
  • DRTS 1
  • GLO 0
  • Target Price
  • DRTS $9.00
  • GLO N/A
  • AVG Volume (30 Days)
  • DRTS 55.6K
  • GLO 170.5K
  • Earning Date
  • DRTS 08-11-2025
  • GLO 01-01-0001
  • Dividend Yield
  • DRTS N/A
  • GLO 11.38%
  • EPS Growth
  • DRTS N/A
  • GLO N/A
  • EPS
  • DRTS N/A
  • GLO N/A
  • Revenue
  • DRTS N/A
  • GLO N/A
  • Revenue This Year
  • DRTS N/A
  • GLO N/A
  • Revenue Next Year
  • DRTS N/A
  • GLO N/A
  • P/E Ratio
  • DRTS N/A
  • GLO N/A
  • Revenue Growth
  • DRTS N/A
  • GLO N/A
  • 52 Week Low
  • DRTS $2.11
  • GLO $4.08
  • 52 Week High
  • DRTS $4.39
  • GLO $5.18
  • Technical
  • Relative Strength Index (RSI)
  • DRTS 54.32
  • GLO 66.04
  • Support Level
  • DRTS $3.06
  • GLO $5.50
  • Resistance Level
  • DRTS $3.58
  • GLO $5.58
  • Average True Range (ATR)
  • DRTS 0.19
  • GLO 0.06
  • MACD
  • DRTS 0.02
  • GLO 0.01
  • Stochastic Oscillator
  • DRTS 57.75
  • GLO 90.48

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.

About GLO Clough Global Opportunities Fund

Clough Global Opportunities Fund is a closed-end management investment company based in the United States. Its investment objective is to provide a high level of total return by investing in equity securities of companies of any market capitalization and equity-related securities, including equity swaps and call options, as well as fixed-income securities, including both corporate and sovereign debt, in both U.S. and non-U.S. markets.

Share on Social Networks: